Back to mobile site

Wells Fargo Upgrades Sutro Biopharma (STRO) to Overweight

March 24, 2026 4:05 AM EDT Send to a Friend
Wells Fargo analyst Eva Fortea-Verdejo upgraded Sutro Biopharma (NASDAQ: STRO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login